{
    "abstract": "Rheumatoid arthritis (RA) is an autoimmune joint disease maintained by aberrant immune responses involving CD4+ T helper (Th)1 and Th17 cells. In this study, we tested the therapeutic efficacy of Ligand Epitope Antigen Presentation System (LEAPS\u2122) vaccines in two Th1 cell-driven mouse models of RA, cartilage proteoglycan (PG)-induced arthritis (PGIA) and PG G1-domain-induced arthritis (GIA). The immunodominant PG peptide PG70 was attached to a DerG or J immune cell binding peptide, and the DerG-PG70 and J-PG70 LEAPS vaccines were administered to the mice after the onset of PGIA or GIA symptoms. As indicated by significant decreases in visual and histopathological scores of arthritis, the DerG-PG70 vaccine inhibited disease progression in both PGIA and GIA, while the J-PG70 vaccine was ineffective. Splenic CD4+ cells from DerG-PG70-treated mice were diminished in Th1 and Th17 populations but enriched in Th2 and regulatory T (Treg) cells. In vitro spleen cell-secreted and serum cytokines from DerG-PG70-treated mice demonstrated a shift from a pro-inflammatory to an anti-inflammatory/regulatory profile. DerG-PG70 peptide tetramers preferentially bound to CD4+ T-cells of GIA spleen cells. We conclude that the DerG-PG70 vaccine (now designated CEL-4000) exerts its therapeutic effect by interacting with CD4+ cells, which results in an antigen-specific down-modulation of pathogenic T-cell responses in both the PGIA and GIA models of RA. Future studies will need to determine the potential of LEAPS vaccination to provide disease suppression in patients with RA.",
    "author_highlights": [
        {
            "endOffset": 19465,
            "sentence": "Therapeutic vaccination with LEAPS peptides offers an alternative to current therapies for rheumatoid arthritis (RA).",
            "startOffset": 19348
        },
        {
            "endOffset": 19608,
            "sentence": "DerG-PG70 LEAPS (CEL-4000) vaccine limits arthritis progression in the GIA and PGIA models of RA when administered after disease is initiated.",
            "startOffset": 19466
        },
        {
            "endOffset": 19767,
            "sentence": "Immunomodulation by CEL-4000 vaccine is indicated by increased ratios of anti-inflammatory to pro-inflammatory/regulatory cytokine production in both systems.",
            "startOffset": 19609
        },
        {
            "endOffset": 19899,
            "sentence": "CEL-4000 has the ability to steer T cells away from pro-inflammatory responses and promote anti-inflammatory/regulatory activities.",
            "startOffset": 19768
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Iain B.",
                    "initial": "I.B.",
                    "last": "McInnes"
                },
                {
                    "first": "Georg",
                    "initial": "G.",
                    "last": "Schett"
                }
            ],
            "doi": "10.1056/NEJMra1004965",
            "firstpage": "2205",
            "issn": "15334406",
            "lastpage": "2219",
            "pmid": "22150039",
            "pub_year": 2011,
            "title": "The pathogenesis of rheumatoid arthritis.",
            "volume": "365"
        },
        "b0010": {
            "authors": [
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Turesson"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Jacobsson"
                },
                {
                    "first": "U.",
                    "initial": "U.",
                    "last": "Bergstr\u00f6m"
                }
            ],
            "doi": "10.1093/rheumatology/38.7.668",
            "firstpage": "668",
            "issn": "14620324",
            "lastpage": "674",
            "pmid": "10461483",
            "pub_year": 1999,
            "title": "Extra-articular rheumatoid arthritis: Prevalence and mortality",
            "volume": "38"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Larry",
                    "initial": "L.",
                    "last": "Moreland"
                }
            ],
            "doi": "10.1186/ar1736",
            "firstpage": "S2",
            "issn": "14786354",
            "lastpage": "S8",
            "pmid": "15960819",
            "pub_year": 2005,
            "title": "Unmet needs in rheumatoid arthritis",
            "volume": "7"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Marita",
                    "initial": "M.",
                    "last": "Cross"
                },
                {
                    "first": "Emma",
                    "initial": "E.",
                    "last": "Smith"
                },
                {
                    "first": "Damian",
                    "initial": "D.",
                    "last": "Hoy"
                },
                {
                    "first": "Loreto",
                    "initial": "L.",
                    "last": "Carmona"
                },
                {
                    "first": "Frederick",
                    "initial": "F.",
                    "last": "Wolfe"
                },
                {
                    "first": "Theo",
                    "initial": "T.",
                    "last": "Vos"
                },
                {
                    "first": "Benjamin",
                    "initial": "B.",
                    "last": "Williams"
                },
                {
                    "first": "Sherine",
                    "initial": "S.",
                    "last": "Gabriel"
                },
                {
                    "first": "Marissa",
                    "initial": "M.",
                    "last": "Lassere"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Johns"
                },
                {
                    "first": "Rachelle",
                    "initial": "R.",
                    "last": "Buchbinder"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Woolf"
                },
                {
                    "first": "Lyn",
                    "initial": "L.",
                    "last": "March"
                }
            ],
            "doi": "10.1136/annrheumdis-2013-204627",
            "firstpage": "1316",
            "issn": "00034967",
            "lastpage": "1322",
            "pmid": "24550173",
            "pub_year": 2014,
            "title": "The global burden of rheumatoid arthritis: Estimates from the Global Burden of Disease 2010 study",
            "volume": "73"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Jeffrey J.",
                    "initial": "J.J.",
                    "last": "Sacks"
                },
                {
                    "first": "Yao Hua",
                    "initial": "Y.H.",
                    "last": "Luo"
                },
                {
                    "first": "Charles G.",
                    "initial": "C.G.",
                    "last": "Helmick"
                }
            ],
            "doi": "10.1002/acr.20041",
            "firstpage": "460",
            "issn": "21514658",
            "lastpage": "464",
            "pmid": "20391499",
            "pub_year": 2010,
            "title": "Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001-2005",
            "volume": "62"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Reka",
                    "initial": "R.",
                    "last": "Kugyelka"
                },
                {
                    "first": "Zoltan",
                    "initial": "Z.",
                    "last": "Kohl"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Olasz"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                },
                {
                    "first": "Tibor A.",
                    "initial": "T.A.",
                    "last": "Rauch"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Ferenc",
                    "initial": "F.",
                    "last": "Boldizsar"
                }
            ],
            "doi": "10.1155/2016/6145810",
            "issn": "09629351",
            "pmid": "26903711",
            "pub_year": 2016,
            "title": "Enigma of IL-17 and Th17 cells in rheumatoid arthritis and in autoimmune animal models of arthritis",
            "volume": "2016"
        },
        "b0035": {
            "authors": [
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Colmegna"
                },
                {
                    "first": "B. R.",
                    "initial": "B.R.",
                    "last": "Ohata"
                },
                {
                    "first": "H. A.",
                    "initial": "H.A.",
                    "last": "Menard"
                }
            ],
            "doi": "10.1038/clpt.2011.325",
            "firstpage": "607",
            "issn": "00099236",
            "lastpage": "620",
            "pmid": "22357455",
            "pub_year": 2012,
            "title": "Current understanding of rheumatoid arthritis therapy",
            "volume": "91"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Josef S.",
                    "initial": "J.S.",
                    "last": "Smolen"
                },
                {
                    "first": "D\u00e9sir\u00e9e",
                    "initial": "D.",
                    "last": "Van Der Heijde"
                },
                {
                    "first": "Klaus P.",
                    "initial": "K.P.",
                    "last": "MacHold"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Aletaha"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Landew\u00e9"
                }
            ],
            "doi": "10.1136/annrheumdis-2013-204317",
            "firstpage": "3",
            "issn": "00034967",
            "lastpage": "5",
            "pmid": "24072562",
            "pub_year": 2014,
            "title": "Proposal for a new nomenclature of disease-modifying antirheumatic drugs",
            "volume": "73"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Mi Ra",
                    "initial": "M.R.",
                    "last": "Chang"
                },
                {
                    "first": "Brent",
                    "initial": "B.",
                    "last": "Lyda"
                },
                {
                    "first": "Theodore M.",
                    "initial": "T.M.",
                    "last": "Kamenecka"
                },
                {
                    "first": "Patrick R.",
                    "initial": "P.R.",
                    "last": "Griffin"
                }
            ],
            "doi": "10.1002/art.38272",
            "firstpage": "579",
            "issn": "23265191",
            "lastpage": "588",
            "pmid": "24574218",
            "pub_year": 2014,
            "title": "Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor \u03b3 is therapeutic in the collagen-induced arthritis experimental model",
            "volume": "66"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Kenneth S.",
                    "initial": "K.S.",
                    "last": "Rosenthal"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                },
                {
                    "first": "Harold L.",
                    "initial": "H.L.",
                    "last": "Steiner"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Finnegan"
                },
                {
                    "first": "Roy E.",
                    "initial": "R.E.",
                    "last": "Carambula"
                },
                {
                    "first": "Daniel H.",
                    "initial": "D.H.",
                    "last": "Zimmerman"
                }
            ],
            "doi": "10.1586/14760584.2015.1026330",
            "firstpage": "891",
            "issn": "14760584",
            "lastpage": "908",
            "pmid": "25787143",
            "pub_year": 2015,
            "title": "Rheumatoid arthritis vaccine therapies: Perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis",
            "volume": "14"
        },
        "b0055": {
            "authors": [
                {
                    "first": "P. R.",
                    "initial": "P.R.",
                    "last": "Taylor"
                },
                {
                    "first": "G. K.",
                    "initial": "G.K.",
                    "last": "Koski"
                },
                {
                    "first": "C. C.",
                    "initial": "C.C.",
                    "last": "Paustian"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Bailey"
                },
                {
                    "first": "P. A.",
                    "initial": "P.A.",
                    "last": "Cohen"
                },
                {
                    "first": "F. B.G.",
                    "initial": "F.B.G.",
                    "last": "Moore"
                },
                {
                    "first": "D. H.",
                    "initial": "D.H.",
                    "last": "Zimmerman"
                },
                {
                    "first": "K. S.",
                    "initial": "K.S.",
                    "last": "Rosenthal"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.06.043",
            "firstpage": "5533",
            "issn": "0264410X",
            "lastpage": "5542",
            "pmid": "20600501",
            "pub_year": 2010,
            "title": "J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells",
            "volume": "28"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Patricia R.",
                    "initial": "P.R.",
                    "last": "Taylor"
                },
                {
                    "first": "Christopher C.",
                    "initial": "C.C.",
                    "last": "Paustian"
                },
                {
                    "first": "Gary K.",
                    "initial": "G.K.",
                    "last": "Koski"
                },
                {
                    "first": "Daniel H.",
                    "initial": "D.H.",
                    "last": "Zimmerman"
                },
                {
                    "first": "Ken S.",
                    "initial": "K.S.",
                    "last": "Rosenthal"
                }
            ],
            "doi": "10.1016/j.cellimm.2010.01.003",
            "firstpage": "1",
            "issn": "00088749",
            "lastpage": "5",
            "pmid": "20163792",
            "pub_year": 2010,
            "title": "Maturation of dendritic cell precursors into IL12-producing DCs by J-LEAPS immunogens",
            "volume": "262"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Ken S.",
                    "initial": "K.S.",
                    "last": "Rosenthal"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Taylor"
                },
                {
                    "first": "Daniel H.",
                    "initial": "D.H.",
                    "last": "Zimmerman"
                }
            ],
            "doi": "10.1111/j.1751-7915.2011.00278.x",
            "firstpage": "203",
            "issn": "17517907",
            "lastpage": "213",
            "pmid": "21895992",
            "pub_year": 2012,
            "title": "J-LEAPS peptide and LEAPS dendritic cell vaccines",
            "volume": "5"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Rolf",
                    "initial": "R.",
                    "last": "K\u00f6nig"
                },
                {
                    "first": "Li Yun",
                    "initial": "L.Y.",
                    "last": "Huang"
                },
                {
                    "first": "Ronald N.",
                    "initial": "R.N.",
                    "last": "Germain"
                }
            ],
            "doi": "10.1038/356796a0",
            "firstpage": "796",
            "issn": "00280836",
            "lastpage": "798",
            "pmid": "1574118",
            "pub_year": 1992,
            "title": "MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8",
            "volume": "356"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Rolf",
                    "initial": "R.",
                    "last": "K\u00f6nig"
                },
                {
                    "first": "Xiaoli",
                    "initial": "X.",
                    "last": "Shen"
                },
                {
                    "first": "Ronald N.",
                    "initial": "R.N.",
                    "last": "Germain"
                }
            ],
            "doi": "10.1084/jem.182.3.779",
            "firstpage": "779",
            "issn": "00221007",
            "lastpage": "787",
            "pmid": "7650484",
            "pub_year": 1995,
            "title": "Involvement of both major histocompatibility complex class II \u03b1 and \u03b2 chains in CD4 function indicates a role for ordered oligomerization in T cell activation",
            "volume": "182"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Xiaoli",
                    "initial": "X.",
                    "last": "Shen"
                },
                {
                    "first": "Bei",
                    "initial": "B.",
                    "last": "Hu"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "McPhie"
                },
                {
                    "first": "Xiaohong",
                    "initial": "X.",
                    "last": "Wu"
                },
                {
                    "first": "Adrienne",
                    "initial": "A.",
                    "last": "Fox"
                },
                {
                    "first": "Ronald N.",
                    "initial": "R.N.",
                    "last": "Germain"
                },
                {
                    "first": "Rolf",
                    "initial": "R.",
                    "last": "K\u00f6nig"
                }
            ],
            "firstpage": "87",
            "issn": "00221767",
            "lastpage": "100",
            "pmid": "8683160",
            "pub_year": 1996,
            "title": "Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo",
            "volume": "157"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Daniel H.",
                    "initial": "D.H.",
                    "last": "Zimmerman"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Taylor"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Bendele"
                },
                {
                    "first": "Roy",
                    "initial": "R.",
                    "last": "Carambula"
                },
                {
                    "first": "Yvonne",
                    "initial": "Y.",
                    "last": "Duzant"
                },
                {
                    "first": "Valeria",
                    "initial": "V.",
                    "last": "Lowe"
                },
                {
                    "first": "Sean P.",
                    "initial": "S.P.",
                    "last": "O'Neill"
                },
                {
                    "first": "Eyal",
                    "initial": "E.",
                    "last": "Talor"
                },
                {
                    "first": "Kenneth S.",
                    "initial": "K.S.",
                    "last": "Rosenthal"
                }
            ],
            "doi": "10.1016/j.intimp.2009.12.016",
            "firstpage": "412",
            "issn": "15675769",
            "lastpage": "421",
            "pmid": "20074669",
            "pub_year": 2010,
            "title": "CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model",
            "volume": "10"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Cihakova"
                },
                {
                    "first": "Jobert G.",
                    "initial": "J.G.",
                    "last": "Barin"
                },
                {
                    "first": "G. Christian",
                    "initial": "G.C.",
                    "last": "Baldeviano"
                },
                {
                    "first": "Miho",
                    "initial": "M.",
                    "last": "Kimura"
                },
                {
                    "first": "Monica V.",
                    "initial": "M.V.",
                    "last": "Talor"
                },
                {
                    "first": "Daniel H.",
                    "initial": "D.H.",
                    "last": "Zimmerman"
                },
                {
                    "first": "Eyal",
                    "initial": "E.",
                    "last": "Talor"
                },
                {
                    "first": "Noel R.",
                    "initial": "N.R.",
                    "last": "Rose"
                }
            ],
            "doi": "10.1016/j.intimp.2008.01.004",
            "firstpage": "624",
            "issn": "15675769",
            "lastpage": "633",
            "pmid": "18387504",
            "pub_year": 2008,
            "title": "L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heart",
            "volume": "8"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Ken S.",
                    "initial": "K.S.",
                    "last": "Rosenthal"
                },
                {
                    "first": "Hanwen",
                    "initial": "H.",
                    "last": "Mao"
                },
                {
                    "first": "Walter I.",
                    "initial": "W.I.",
                    "last": "Horne"
                },
                {
                    "first": "Craig",
                    "initial": "C.",
                    "last": "Wright"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Zimmerman"
                }
            ],
            "doi": "10.1016/S0264-410X(98)00231-X",
            "firstpage": "535",
            "issn": "0264410X",
            "lastpage": "542",
            "pmid": "10075159",
            "pub_year": 1999,
            "title": "Immunization with a LEAPS(TM) heteroconjugate containing a CTL epitope and a peptide from beta-2-microglobulin elicits a protective and DTH response to herpes simplex virus type 1",
            "volume": "17"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Kobporn",
                    "initial": "K.",
                    "last": "Boonnak"
                },
                {
                    "first": "Leatrice",
                    "initial": "L.",
                    "last": "Vogel"
                },
                {
                    "first": "Marlene",
                    "initial": "M.",
                    "last": "Orandle"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Zimmerman"
                },
                {
                    "first": "Eyal",
                    "initial": "E.",
                    "last": "Talor"
                },
                {
                    "first": "Kanta",
                    "initial": "K.",
                    "last": "Subbarao"
                }
            ],
            "doi": "10.1172/JCI67550",
            "firstpage": "2850",
            "issn": "00219738",
            "lastpage": "2861",
            "pmid": "23934125",
            "pub_year": 2013,
            "title": "Antigen-activated dendritic cells ameliorate influenza A infections",
            "volume": "123"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                },
                {
                    "first": "Artin",
                    "initial": "A.",
                    "last": "Arzoumanian"
                },
                {
                    "first": "A. Robin",
                    "initial": "A.R.",
                    "last": "Poole"
                }
            ],
            "doi": "10.1002/art.1780300211",
            "firstpage": "201",
            "issn": "00043591",
            "lastpage": "212",
            "pmid": "3827960",
            "pub_year": 1987,
            "title": "Proteoglycan\u2010induced arthritis in balb/c mice",
            "volume": "30"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Marianna",
                    "initial": "M.",
                    "last": "Radacs"
                },
                {
                    "first": "Gyorgy",
                    "initial": "G.",
                    "last": "Nagyeri"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Olasz"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Laszlo"
                },
                {
                    "first": "Ferenc",
                    "initial": "F.",
                    "last": "Boldizsar"
                },
                {
                    "first": "Akos",
                    "initial": "A.",
                    "last": "Hegyi"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Finnegan"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                }
            ],
            "doi": "10.1002/art.30261",
            "firstpage": "1312",
            "issn": "00043591",
            "lastpage": "1321",
            "pmid": "21305522",
            "pub_year": 2011,
            "title": "Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis",
            "volume": "63"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Paul D.",
                    "initial": "P.D.",
                    "last": "Doodes"
                },
                {
                    "first": "Yanxia",
                    "initial": "Y.",
                    "last": "Cao"
                },
                {
                    "first": "Keith M.",
                    "initial": "K.M.",
                    "last": "Hamel"
                },
                {
                    "first": "Yumei",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Balint",
                    "initial": "B.",
                    "last": "Farkas"
                },
                {
                    "first": "Yoichiro",
                    "initial": "Y.",
                    "last": "Iwakura"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Finnegan"
                }
            ],
            "doi": "10.4049/jimmunol.181.1.329",
            "firstpage": "329",
            "issn": "00221767",
            "lastpage": "337",
            "pmid": "18566398",
            "pub_year": 2008,
            "title": "Development of proteoglycan-induced arthritis is independent of IL-17",
            "volume": "181"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Finnegan"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                },
                {
                    "first": "Ping",
                    "initial": "P.",
                    "last": "Tao"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                }
            ],
            "firstpage": "5383",
            "issn": "00221767",
            "lastpage": "5390",
            "pmid": "10553063",
            "pub_year": 1999,
            "title": "Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines",
            "volume": "163"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Hanyecz"
                },
                {
                    "first": "Suzanne E.",
                    "initial": "S.E.",
                    "last": "Berlo"
                },
                {
                    "first": "S\u00e1ndor",
                    "initial": "S.",
                    "last": "Sz\u00e1nt\u00f3"
                },
                {
                    "first": "Chris P.M.",
                    "initial": "C.P.M.",
                    "last": "Broeren"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                }
            ],
            "doi": "10.1002/art.20180",
            "firstpage": "1665",
            "issn": "00043591",
            "lastpage": "1676",
            "pmid": "15146438",
            "pub_year": 2004,
            "title": "Achievement of a Synergistic Adjuvant Effect on Arthritis Induction by Activation of Innate Immunity and Forcing the Immune Response Toward the Th1 Phenotype",
            "volume": "50"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "A. Robin",
                    "initial": "A.R.",
                    "last": "Poole"
                }
            ],
            "doi": "10.1002/art.1780300310",
            "firstpage": "306",
            "issn": "00043591",
            "lastpage": "318",
            "pmid": "3566822",
            "pub_year": 1987,
            "title": "Immunity to cartilage proteoglycans in balb/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan",
            "volume": "30"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Finnegan"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                }
            ],
            "doi": "10.1615/CritRevImmunol.v23.i3.20",
            "firstpage": "199",
            "issn": "10408401",
            "lastpage": "250",
            "pmid": "14584879",
            "pub_year": 2003,
            "title": "Proteoglycan-induced arthritis: Immune regulation, cellular mechanisms, and genetics",
            "volume": "23"
        },
        "b0140": {
            "authors": [
                {
                    "first": "J\u00falia",
                    "initial": "J.",
                    "last": "Kurk\u00f3"
                },
                {
                    "first": "Andr\u00e1s",
                    "initial": "A.",
                    "last": "Vida"
                },
                {
                    "first": "T\u00edmea",
                    "initial": "T.",
                    "last": "Ocsk\u00f3"
                },
                {
                    "first": "Beata",
                    "initial": "B.",
                    "last": "Tryniszewska"
                },
                {
                    "first": "Tibor A.",
                    "initial": "T.A.",
                    "last": "Rauch"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Zolt\u00e1n",
                    "initial": "Z.",
                    "last": "Szekanecz"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                }
            ],
            "doi": "10.1371/journal.pone.0111815",
            "issn": "19326203",
            "pmid": "25369029",
            "pub_year": 2014,
            "title": "Suppression of proteoglycan-Induced autoimmune arthritis by myeloid-Derived suppressor cells generated in vitro from murine bone marrow",
            "volume": "9"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Colt",
                    "initial": "C.",
                    "last": "Egelston"
                },
                {
                    "first": "J\u00falia",
                    "initial": "J.",
                    "last": "Kurk\u00f3"
                },
                {
                    "first": "Timea",
                    "initial": "T.",
                    "last": "Besenyei"
                },
                {
                    "first": "Beata",
                    "initial": "B.",
                    "last": "Tryniszewska"
                },
                {
                    "first": "Tibor A.",
                    "initial": "T.A.",
                    "last": "Rauch"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                }
            ],
            "doi": "10.1002/art.34494",
            "firstpage": "3179",
            "issn": "00043591",
            "lastpage": "3188",
            "pmid": "22492217",
            "pub_year": 2012,
            "title": "Suppression of dendritic cell maturation and T cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis",
            "volume": "64"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Tam\u00e1s",
                    "initial": "T.",
                    "last": "Kobezda"
                },
                {
                    "first": "Sheida",
                    "initial": "S.",
                    "last": "Ghassemi-Nejad"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                }
            ],
            "doi": "10.1016/j.cellimm.2012.08.003",
            "firstpage": "158",
            "issn": "00088749",
            "lastpage": "165",
            "pmid": "23023071",
            "pub_year": 2012,
            "title": "In vivo two-photon imaging of T cell motility in joint-draining lymph nodes in a mouse model of rheumatoid arthritis",
            "volume": "278"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Zhenzhen",
                    "initial": "Z.",
                    "last": "Liu"
                },
                {
                    "first": "Paul A.",
                    "initial": "P.A.",
                    "last": "Roche"
                }
            ],
            "doi": "10.3389/fphys.2015.00001",
            "issn": "1664042X",
            "pub_year": 2015,
            "title": "Macropinocytosis in phagocytes: Regulation of MHC class-II-restricted antigen presentation in dendritic cells",
            "volume": "6"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Shannon K.",
                    "initial": "S.K.",
                    "last": "O'Neill"
                },
                {
                    "first": "Mark J.",
                    "initial": "M.J.",
                    "last": "Shlomchik"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Yanxia",
                    "initial": "Y.",
                    "last": "Cao"
                },
                {
                    "first": "Paul D.",
                    "initial": "P.D.",
                    "last": "Doodes"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Finnegan"
                }
            ],
            "doi": "10.4049/jimmunol.174.6.3781",
            "firstpage": "3781",
            "issn": "00221767",
            "lastpage": "3788",
            "pmid": "15749919",
            "pub_year": 2005,
            "title": "Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis",
            "volume": "174"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Giancarlo",
                    "initial": "G.",
                    "last": "Cammarota"
                },
                {
                    "first": "Armella",
                    "initial": "A.",
                    "last": "Scheirle"
                },
                {
                    "first": "Bela",
                    "initial": "B.",
                    "last": "Takacs"
                },
                {
                    "first": "Daniel M.",
                    "initial": "D.M.",
                    "last": "Doran"
                },
                {
                    "first": "Reinhard",
                    "initial": "R.",
                    "last": "Knorr"
                },
                {
                    "first": "Willi",
                    "initial": "W.",
                    "last": "Bannwarth"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Guardiola"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Sinigaglia"
                }
            ],
            "doi": "10.1038/356799a0",
            "firstpage": "799",
            "issn": "00280836",
            "lastpage": "801",
            "pmid": "1574119",
            "pub_year": 1992,
            "title": "Identification of a CD4 binding site on the \u03b22 domain of HLA-DR molecules",
            "volume": "356"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Daniel H.",
                    "initial": "D.H.",
                    "last": "Zimmerman"
                },
                {
                    "first": "Harold",
                    "initial": "H.",
                    "last": "Steiner"
                },
                {
                    "first": "Roy",
                    "initial": "R.",
                    "last": "Carmabula"
                },
                {
                    "first": "Eyal",
                    "initial": "E.",
                    "last": "Talor"
                },
                {
                    "first": "Ken S.",
                    "initial": "K.S.",
                    "last": "Rosenthal"
                }
            ],
            "doi": "10.4172/2157-7560.1000149",
            "issn": "21577560",
            "pub_year": 2012,
            "title": "LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases",
            "volume": "3"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Paul D.",
                    "initial": "P.D.",
                    "last": "Doodes"
                },
                {
                    "first": "Yanxia",
                    "initial": "Y.",
                    "last": "Cao"
                },
                {
                    "first": "Keith M.",
                    "initial": "K.M.",
                    "last": "Hamel"
                },
                {
                    "first": "Yumei",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Rachel L.",
                    "initial": "R.L.",
                    "last": "Rodeghero"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Yoichiro",
                    "initial": "Y.",
                    "last": "Iwakura"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Finnegan"
                }
            ],
            "doi": "10.4049/jimmunol.0902907",
            "firstpage": "1552",
            "issn": "00221767",
            "lastpage": "1559",
            "pmid": "20028652",
            "pub_year": 2010,
            "title": "IFN-\u03b3 regulates the requirement for IL-17 in proteoglycan-induced arthritis",
            "volume": "184"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Adrienn",
                    "initial": "A.",
                    "last": "Markovics"
                },
                {
                    "first": "T\u00edmea",
                    "initial": "T.",
                    "last": "Ocsk\u00f3"
                },
                {
                    "first": "Robert S.",
                    "initial": "R.S.",
                    "last": "Katz"
                },
                {
                    "first": "Edit I.",
                    "initial": "E.I.",
                    "last": "Buz\u00e1s"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                }
            ],
            "doi": "10.1371/journal.pone.0160284",
            "issn": "19326203",
            "pmid": "27466816",
            "pub_year": 2016,
            "title": "Immune recognition of citrullinated proteoglycan aggrecan epitopes in mice with proteoglycan-induced arthritis and in patients with rheumatoid arthritis",
            "volume": "11"
        },
        "b0185": {
            "authors": [
                {
                    "first": "D. H.",
                    "initial": "D.H.",
                    "last": "Zimmerman"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Morris"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Rouse"
                },
                {
                    "first": "K. F.W.",
                    "initial": "K.F.W.",
                    "last": "Worthington"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Elliott"
                },
                {
                    "first": "K. S.",
                    "initial": "K.S.",
                    "last": "Rosenthal"
                }
            ],
            "firstpage": "103",
            "issn": "10567909",
            "lastpage": "118",
            "pub_year": 1996,
            "title": "Immunization with peptide heteroconjugates primes a T helper cell type 1-associated antibody (IgG2a) response that recognizes the native epitope on the 38-kDa protein of Mycobacterium tuberculosis",
            "volume": "5"
        },
        "b0190": {
            "authors": [
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Goel"
                },
                {
                    "first": "Q.",
                    "initial": "Q.",
                    "last": "Rong"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Zimmerman"
                },
                {
                    "first": "K. S.",
                    "initial": "K.S.",
                    "last": "Rosenthal"
                }
            ],
            "doi": "10.1016/S0264-410X(03)00429-8",
            "firstpage": "4410",
            "issn": "0264410X",
            "lastpage": "4420",
            "pmid": "14505924",
            "pub_year": 2003,
            "title": "A L.E.A.P.S.\u2122 heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection",
            "volume": "21"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Edit I.",
                    "initial": "E.I.",
                    "last": "Buz\u00e1s"
                },
                {
                    "first": "Anik\u00f3",
                    "initial": "A.",
                    "last": "V\u00e9gv\u00e1ri"
                },
                {
                    "first": "Yanal M.",
                    "initial": "Y.M.",
                    "last": "Murad"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Finnegan"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                }
            ],
            "doi": "10.1016/j.cellimm.2004.08.006",
            "firstpage": "98",
            "issn": "00088749",
            "lastpage": "108",
            "pmid": "16185673",
            "pub_year": 2005,
            "title": "T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis",
            "volume": "235"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "Edit I.",
                    "initial": "E.I.",
                    "last": "Buz\u00e1s"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Finnegan"
                },
                {
                    "first": "Gabriela",
                    "initial": "G.",
                    "last": "Negroiu"
                },
                {
                    "first": "Gabriella",
                    "initial": "G.",
                    "last": "Cs-Szab\u00f3"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                }
            ],
            "firstpage": "3812",
            "issn": "00221767",
            "lastpage": "3819",
            "pmid": "9558085",
            "pub_year": 1998,
            "title": "Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation",
            "volume": "160"
        },
        "b0205": {
            "authors": [
                {
                    "first": "S\u00e1ndor",
                    "initial": "S.",
                    "last": "Sz\u00e1nt\u00f3"
                },
                {
                    "first": "Tam\u00e1s",
                    "initial": "T.",
                    "last": "B\u00e1rdos"
                },
                {
                    "first": "Zolt\u00e1n",
                    "initial": "Z.",
                    "last": "Szab\u00f3"
                },
                {
                    "first": "Chella S.",
                    "initial": "C.S.",
                    "last": "David"
                },
                {
                    "first": "Edit I.",
                    "initial": "E.I.",
                    "last": "Buz\u00e1s"
                },
                {
                    "first": "Katalin",
                    "initial": "K.",
                    "last": "Mikecz"
                },
                {
                    "first": "Tibor T.",
                    "initial": "T.T.",
                    "last": "Glant"
                }
            ],
            "doi": "10.1002/art.20285",
            "firstpage": "1984",
            "issn": "00043591",
            "lastpage": "1995",
            "pmid": "15188376",
            "pub_year": 2004,
            "title": "Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (Non-MHC) genetic background",
            "volume": "50"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Alexei",
                    "initial": "A.",
                    "last": "Guerassimov"
                },
                {
                    "first": "Yiping",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Subhashis",
                    "initial": "S.",
                    "last": "Banerjee"
                },
                {
                    "first": "Annie",
                    "initial": "A.",
                    "last": "Cartman"
                },
                {
                    "first": "Jean Yves",
                    "initial": "J.Y.",
                    "last": "Leroux"
                },
                {
                    "first": "Lawrence C.",
                    "initial": "L.C.",
                    "last": "Rosenberg"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Esdaile"
                },
                {
                    "first": "Mary Ann",
                    "initial": "M.A.",
                    "last": "Fitzcharles"
                },
                {
                    "first": "A. Robin",
                    "initial": "A.R.",
                    "last": "Poole"
                }
            ],
            "doi": "10.1002/1529-0131(199806)41:6<1019::AID-ART8>3.0.CO;2-X",
            "firstpage": "1019",
            "issn": "00043591",
            "lastpage": "1025",
            "pmid": "9627011",
            "pub_year": 1998,
            "title": "Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate",
            "volume": "41"
        },
        "b0215": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "De Jong"
                },
                {
                    "first": "S. E.",
                    "initial": "S.E.",
                    "last": "Berlo"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Hombrink"
                },
                {
                    "first": "H. G.",
                    "initial": "H.G.",
                    "last": "Otten"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Van Eden"
                },
                {
                    "first": "F. P.",
                    "initial": "F.P.",
                    "last": "Lafeber"
                },
                {
                    "first": "A. H.M.",
                    "initial": "A.H.M.",
                    "last": "Heurkens"
                },
                {
                    "first": "J. W.J.",
                    "initial": "J.W.J.",
                    "last": "Bijlsma"
                },
                {
                    "first": "T. T.",
                    "initial": "T.T.",
                    "last": "Glant"
                },
                {
                    "first": "B. J.",
                    "initial": "B.J.",
                    "last": "Prakken"
                }
            ],
            "doi": "10.1136/ard.2008.103978",
            "firstpage": "255",
            "issn": "00034967",
            "lastpage": "262",
            "pmid": "19213744",
            "pub_year": 2010,
            "title": "Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T-cell responses in rheumatoid arthritis and osteoarthritis",
            "volume": "69"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Alexei",
                    "initial": "A.",
                    "last": "Von Delwig"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Locke"
                },
                {
                    "first": "John H.",
                    "initial": "J.H.",
                    "last": "Robinson"
                },
                {
                    "first": "Wan Fai",
                    "initial": "W.F.",
                    "last": "Ng"
                }
            ],
            "doi": "10.1002/art.25064",
            "firstpage": "143",
            "issn": "00043591",
            "lastpage": "149",
            "pmid": "20039419",
            "pub_year": 2010,
            "title": "Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis",
            "volume": "62"
        },
        "b0225": {
            "authors": [
                {
                    "first": "Soi C.",
                    "initial": "S.C.",
                    "last": "Law"
                },
                {
                    "first": "Shayna",
                    "initial": "S.",
                    "last": "Street"
                },
                {
                    "first": "Chien Hsiung A.",
                    "initial": "C.H.A.",
                    "last": "Yu"
                },
                {
                    "first": "Christelle",
                    "initial": "C.",
                    "last": "Capini"
                },
                {
                    "first": "Sakoontalla",
                    "initial": "S.",
                    "last": "Ramnoruth"
                },
                {
                    "first": "Hendrik J.",
                    "initial": "H.J.",
                    "last": "Nel"
                },
                {
                    "first": "Eline",
                    "initial": "E.",
                    "last": "van Gorp"
                },
                {
                    "first": "Claire",
                    "initial": "C.",
                    "last": "Hyde"
                },
                {
                    "first": "Kim",
                    "initial": "K.",
                    "last": "Lau"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Pahau"
                },
                {
                    "first": "Anthony W.",
                    "initial": "A.W.",
                    "last": "Purcell"
                },
                {
                    "first": "Ranjeny",
                    "initial": "R.",
                    "last": "Thomas"
                }
            ],
            "doi": "10.1186/ar3848",
            "issn": "14786354",
            "pmid": "22594821",
            "pub_year": 2012,
            "title": "T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles",
            "volume": "14"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Lutterotti"
                },
                {
                    "first": "Sara",
                    "initial": "S.",
                    "last": "Yousef"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Sputtek"
                },
                {
                    "first": "Klarissa H.",
                    "initial": "K.H.",
                    "last": "St\u00fcrner"
                },
                {
                    "first": "Jan Patrick",
                    "initial": "J.P.",
                    "last": "Stellmann"
                },
                {
                    "first": "Petra",
                    "initial": "P.",
                    "last": "Breiden"
                },
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "Reinhardt"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Schulze"
                },
                {
                    "first": "Maxim",
                    "initial": "M.",
                    "last": "Bester"
                },
                {
                    "first": "Christoph",
                    "initial": "C.",
                    "last": "Heesen"
                },
                {
                    "first": "Sven",
                    "initial": "S.",
                    "last": "Schippling"
                },
                {
                    "first": "Stephen D.",
                    "initial": "S.D.",
                    "last": "Miller"
                },
                {
                    "first": "Mireia",
                    "initial": "M.",
                    "last": "Sospedra"
                },
                {
                    "first": "Roland",
                    "initial": "R.",
                    "last": "Martin"
                }
            ],
            "doi": "10.1126/scitranslmed.3006168",
            "issn": "19466234",
            "pmid": "23740901",
            "pub_year": 2013,
            "title": "Antigen-specific tolerance by autologous myelin peptide-coupled cells: A phase 1 trial in multiple sclerosis",
            "volume": "5"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Marek-Trzonkowska"
                },
                {
                    "first": "Ma\u0142gorzata",
                    "initial": "M.",
                    "last": "My\u015bliwiec"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Iwaszkiewicz-Grze\u015b"
                },
                {
                    "first": "Mateusz",
                    "initial": "M.",
                    "last": "Gliwi\u0144ski"
                },
                {
                    "first": "Ilona",
                    "initial": "I.",
                    "last": "Derkowska"
                },
                {
                    "first": "Magdalena",
                    "initial": "M.",
                    "last": "Zali\u0144ska"
                },
                {
                    "first": "Maciej",
                    "initial": "M.",
                    "last": "Zieli\u0144ski"
                },
                {
                    "first": "Marcelina",
                    "initial": "M.",
                    "last": "Grabowska"
                },
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Zieli\u0144ska"
                },
                {
                    "first": "Karolina",
                    "initial": "K.",
                    "last": "Piekarska"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Ja\u017awi\u0144ska-Cury\u0142\u0142o"
                },
                {
                    "first": "Rados\u0142aw",
                    "initial": "R.",
                    "last": "Owczuk"
                },
                {
                    "first": "Agnieszka",
                    "initial": "A.",
                    "last": "Szadkowska"
                },
                {
                    "first": "Krystyna",
                    "initial": "K.",
                    "last": "Wyka"
                },
                {
                    "first": "Piotr",
                    "initial": "P.",
                    "last": "Witkowski"
                },
                {
                    "first": "Wojciech",
                    "initial": "W.",
                    "last": "M\u0142ynarski"
                },
                {
                    "first": "Przemys\u0142awa",
                    "initial": "P.",
                    "last": "Jarosz-Chobot"
                },
                {
                    "first": "Artur",
                    "initial": "A.",
                    "last": "Bossowski"
                },
                {
                    "first": "Janusz",
                    "initial": "J.",
                    "last": "Siebert"
                },
                {
                    "first": "Piotr",
                    "initial": "P.",
                    "last": "Trzonkowski"
                }
            ],
            "doi": "10.1186/s12967-016-1090-7",
            "issn": "14795876",
            "pmid": "27903296",
            "pub_year": 2016,
            "title": "Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes",
            "volume": "14"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Douglas C.",
                    "initial": "D.C.",
                    "last": "Palmer"
                },
                {
                    "first": "Sanjeeve",
                    "initial": "S.",
                    "last": "Balasubramaniam"
                },
                {
                    "first": "Ken Ichi",
                    "initial": "K.I.",
                    "last": "Hanada"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Wrzesinski"
                },
                {
                    "first": "Zhiya",
                    "initial": "Z.",
                    "last": "Yu"
                },
                {
                    "first": "Shahram",
                    "initial": "S.",
                    "last": "Farid"
                },
                {
                    "first": "Marc R.",
                    "initial": "M.R.",
                    "last": "Theoret"
                },
                {
                    "first": "Leroy N.",
                    "initial": "L.N.",
                    "last": "Hwang"
                },
                {
                    "first": "Christopher A.",
                    "initial": "C.A.",
                    "last": "Klebanoff"
                },
                {
                    "first": "Luca",
                    "initial": "L.",
                    "last": "Gattinoni"
                },
                {
                    "first": "Allan L.",
                    "initial": "A.L.",
                    "last": "Goldstein"
                },
                {
                    "first": "James C.",
                    "initial": "J.C.",
                    "last": "Yang"
                },
                {
                    "first": "Nicholas P.",
                    "initial": "N.P.",
                    "last": "Restifo"
                }
            ],
            "doi": "10.4049/jimmunol.173.12.7209",
            "firstpage": "7209",
            "issn": "00221767",
            "lastpage": "7216",
            "pmid": "15585842",
            "pub_year": 2004,
            "title": "Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction",
            "volume": "173"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Angela M.",
                    "initial": "A.M.",
                    "last": "Tatum"
                },
                {
                    "first": "Lawrence M.",
                    "initial": "L.M.",
                    "last": "Mylin"
                },
                {
                    "first": "Susan J.",
                    "initial": "S.J.",
                    "last": "Bender"
                },
                {
                    "first": "Matthew A.",
                    "initial": "M.A.",
                    "last": "Fischer"
                },
                {
                    "first": "Beth A.",
                    "initial": "B.A.",
                    "last": "Vigliotti"
                },
                {
                    "first": "M. Judith",
                    "initial": "M.J.",
                    "last": "Tevethia"
                },
                {
                    "first": "Satvir S.",
                    "initial": "S.S.",
                    "last": "Tevethia"
                },
                {
                    "first": "Todd D.",
                    "initial": "T.D.",
                    "last": "Schell"
                }
            ],
            "doi": "10.4049/jimmunol.181.6.4406",
            "firstpage": "4406",
            "issn": "00221767",
            "lastpage": "4417",
            "pmid": "18768900",
            "pub_year": 2008,
            "title": "CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors",
            "volume": "181"
        },
        "s0145": null
    },
    "body_text": [
        {
            "endOffset": 31698,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0075",
            "sentence": "Results are presented as mean \u00b1 SEM.",
            "startOffset": 31662,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 31948,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0075",
            "sentence": "P values less than 0.05 were accepted as statistically significant (Material handling and data collection details as described).3",
            "startOffset": 31819,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 41306,
            "parents": [],
            "secId": "s0120",
            "sentence": "As in RA, the inflammatory disease in both the PGIA and GIA models is driven and sustained primarily by Th1 but also by Th17 cells and cytokines produced by them.",
            "startOffset": 41144,
            "title": "Discussion"
        },
        {
            "endOffset": 40648,
            "parents": [],
            "secId": "s0120",
            "sentence": "Since Th1-dominated diseases might benefit from a shift away from the pro-inflammatory Th1 to a more balanced Th2 or Treg response, our hypothesis was that treatment with a Th2-promoting DerG LEAPS heteroconjugate incorporating PG70 would initiate an antigen specific response to ameliorate the arthritis symptoms, while a Th1-promoting J-LEAPS heteroconjugate with PG70 would either have no effect or exacerbate disease.",
            "startOffset": 40227,
            "title": "Discussion"
        },
        {
            "endOffset": 28071,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0030",
            "sentence": "Doses (100 nmol) of LEAPS conjugates or individual peptides were prepared in 100 \u00b5l sterile PBS (pH 7.2) and emulsified at a 1:1 ratio with Montanide ISA-51VG adjuvant (Seppic, Paris, France).",
            "startOffset": 27879,
            "title": "Vaccine treatment of mice with PGIA or GIA"
        },
        {
            "endOffset": 25125,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 25041,
                    "startOffset": 25034
                },
                "b0115": {
                    "endOffset": 25041,
                    "startOffset": 25034
                },
                "b0120": {
                    "endOffset": 25041,
                    "startOffset": 25034
                },
                "b0125": {
                    "endOffset": 25041,
                    "startOffset": 25034
                }
            },
            "secId": "s0005",
            "sentence": "Both the PGIA and GIA models are predominantly driven by Th1 interferon-gamma (IFN\u03b3) responses [22\u201325], and generate Th17 as well as other pro- and anti-inflammatory cytokines responses.",
            "startOffset": 24939,
            "title": "Introduction"
        },
        {
            "endOffset": 32361,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0090",
            "sentence": "The therapeutic activities of LEAPS vaccines containing Der-G-PG70 or J-PG70 peptide conjugates (emulsified with Seppic ISA-51VG adjuvant) were compared to controls containing vehicle (PBS with or without adjuvant), in the PGIA (Fig. 1A: Study 1) and GIA (Fig. 1B: Study 2, and Fig. 1C: Study 3) models of RA.",
            "startOffset": 32052,
            "title": "Visual arthritis (VA) scores"
        },
        {
            "endOffset": 42138,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 42137,
                    "startOffset": 42133
                }
            },
            "secId": "s0120",
            "sentence": "There is more robust production of IFN\u03b3 in the GIA model compared to the PGIA model, as seen herein and an earlier study [22].",
            "startOffset": 42012,
            "title": "Discussion"
        },
        {
            "endOffset": 43243,
            "parents": [],
            "secId": "s0120",
            "sentence": "The binding studies suggest that the DerG-PG70 conjugate modulates T-cell responses via direct binding to CD4+ T-cells in the PGIA and GIA mice.",
            "startOffset": 43099,
            "title": "Discussion"
        },
        {
            "endOffset": 44565,
            "parents": [],
            "secId": "s0120",
            "sentence": "As such, knowledge of signature T-cell cytokine phenotypes that drive the patient\u2019s disease can facilitate the choice of the appropriate LEAPS vaccine therapy.",
            "startOffset": 44406,
            "title": "Discussion"
        },
        {
            "endOffset": 29726,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 29607,
                    "startOffset": 29603
                }
            },
            "secId": "s0050",
            "sentence": "The percentages of Th (CD4+) spleen cells containing intracellular cytokines or Foxp3 in cultures of antigen-stimulated spleen cells were determined by flow cytometry [28] on a BD FACS Canto II flow cytometer and analyzed using FACS Diva software (BD Flow Cytometry Systems, San Jose, CA).3",
            "startOffset": 29436,
            "title": "Determination of T-cell phenotypes and cytokine profiles by flow cytometry"
        },
        {
            "endOffset": 38844,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "The binding of tetramers of DerG-PG70, J-PG70, and their component peptides to spleen cells from GIA mice and BM-derived DCs from normal mice was examined in vitro to identify the cell types that can be affected by treatment.",
            "startOffset": 38619,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 23332,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 23331,
                    "startOffset": 23327
                }
            },
            "secId": "s0005",
            "sentence": "In contrast to other therapies for RA, therapeutic vaccines focus on the antigen specific disease-driving cells that are upstream of disease presentation to modulate the pro-inflammatory Th1 or Th17 responses or enhance regulatory T-cell (Treg) responses in a beneficial manner [10].",
            "startOffset": 23049,
            "title": "Introduction"
        },
        {
            "endOffset": 26414,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0015",
            "sentence": "Biotinylated peptides were purchased from Biomatik, Inc. (Wilmington, DE).",
            "startOffset": 26340,
            "title": "Peptides"
        },
        {
            "endOffset": 28614,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0035",
            "sentence": "After blood draw, the anesthetized mice were euthanized via CO2 inhalation.",
            "startOffset": 28539,
            "title": "Collection of blood and tissues from mice"
        },
        {
            "endOffset": 29947,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0055",
            "sentence": "For cytokine secretion studies, spleen cells were either left untreated (native cultures) or treated with human PG or rhG1 (for PGIA and GIA cells, respectively) as specified above.",
            "startOffset": 29766,
            "title": "Assays of in vitro cytokine secretion"
        },
        {
            "endOffset": 28302,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0030",
            "sentence": "The mice were treated first on the day of initial grouping (day 0) and the same dose was administered s.c. on day 14.",
            "startOffset": 28185,
            "title": "Vaccine treatment of mice with PGIA or GIA"
        },
        {
            "endOffset": 33188,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0095",
            "sentence": "Histopathological changes in the joints, induced by autoimmune inflammatory damage, or as modulated by vaccine treatment, were evaluated in comparison with normal joints of na\u00efve mice (see Supplementary Figs. 1 and 2).3",
            "startOffset": 32969,
            "title": "Histopathological changes"
        },
        {
            "endOffset": 34377,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0095",
            "sentence": "The in vivo VA scores (Fig. 1) and joint histopathology (Table 1 and Supplementary Figs. 1 and 2) indicate that DerG-PG70 treatment of PGIA and GIA mice had a consistent and reproducible therapeutic effect.",
            "startOffset": 34171,
            "title": "Histopathological changes"
        },
        {
            "endOffset": 26339,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0015",
            "sentence": "Peptides were purchased from 21st Century Biochemicals (Marlborough, MA) or Ambiopharm (North Augusta, SC) at \u226595% purity with amino acid sequences and mass confirmed by mass spectrometry.",
            "startOffset": 26151,
            "title": "Peptides"
        },
        {
            "endOffset": 22201,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 22200,
                    "startOffset": 22197
                }
            },
            "secId": "s0005",
            "sentence": "Current treatment of RA largely focuses on alleviation of symptoms and delaying disease progression [7].",
            "startOffset": 22097,
            "title": "Introduction"
        },
        {
            "endOffset": 22097,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 22096,
                    "startOffset": 22093
                }
            },
            "secId": "s0005",
            "sentence": "Although the initiating events of RA are unknown, the disease is maintained by pro-inflammatory mediators produced during T helper (primarily Th1 and Th17) cell-driven autoimmune responses [1].",
            "startOffset": 21904,
            "title": "Introduction"
        },
        {
            "endOffset": 39801,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "Therefore, the net mean fluorescence intensity levels (above the SA-PE background) were calculated as a measure of specific peptide binding to cells (Fig. 5B).",
            "startOffset": 39642,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 22611,
            "parents": [],
            "secId": "s0005",
            "sentence": "The pro-inflammatory cytokine interleukin (IL)17 has become a popular target for treating the inflammation associated with RA.",
            "startOffset": 22485,
            "title": "Introduction"
        },
        {
            "endOffset": 30990,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 30989,
                    "startOffset": 30982
                },
                "b0145": {
                    "endOffset": 30989,
                    "startOffset": 30982
                }
            },
            "secId": "s0065",
            "sentence": "BM was obtained from na\u00efve mice and was enriched in DCs as described previously [28,29].",
            "startOffset": 30902,
            "title": "Generation of bone marrow-derived dendritic cells (BM-DCs)"
        },
        {
            "endOffset": 42874,
            "parents": [],
            "refoffsets": {
                "b0160": {
                    "endOffset": 42873,
                    "startOffset": 42869
                }
            },
            "secId": "s0120",
            "sentence": "Using the SA-PE-peptide tetramers it was possible to demonstrate that the DerG-PG70 conjugate preferentially bound to splenic CD4+ Th (or Treg) cells, whereas J-PG70 showed preference for binding to MHC II-bearing APCs and CD11c+ DCs, known to be involved in PGIA [32].",
            "startOffset": 42605,
            "title": "Discussion"
        },
        {
            "endOffset": 24130,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 24006,
                    "startOffset": 23999
                },
                "b0060": {
                    "endOffset": 24006,
                    "startOffset": 23999
                },
                "b0065": {
                    "endOffset": 24006,
                    "startOffset": 23999
                },
                "b0070": {
                    "endOffset": 24129,
                    "startOffset": 24122
                },
                "b0075": {
                    "endOffset": 24129,
                    "startOffset": 24122
                },
                "b0080": {
                    "endOffset": 24129,
                    "startOffset": 24122
                }
            },
            "secId": "s0005",
            "sentence": "The J peptide ICBL is from human \u03b22 microglobulin and acts first on dendritic cells (DC) [11\u201313] and the DerG peptide from domain 2 of the \u03b2 chain of the human MHC class II (HLA-DR) molecule acts on CD4+ T cells [14\u201316].",
            "startOffset": 23910,
            "title": "Introduction"
        },
        {
            "endOffset": 33352,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0095",
            "sentence": "Table 1 shows the individual and cumulative histopathology scores of the limbs of GIA mice (Study 2 and Study 3) after the animals underwent the in vivo treatments.",
            "startOffset": 33188,
            "title": "Histopathological changes"
        },
        {
            "endOffset": 36739,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "These ratios reflect the reductions in pro-inflammatory cytokines (IFN\u03b3 and IL17(A + F)) and increases in anti-inflammatory cytokines (IL4, TGF\u03b2, and IL10) due to DerG-PG70 vaccine treatment, as compared to control treatment in all the PGIA cultures, although the differences did not always reach significance (Supplementary Figs. 3A and 3B).3",
            "startOffset": 36396,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 30674,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0055",
            "sentence": "For the GIA studies, multiple cytokines were measured using the multi-plex mouse Th17 kit (IL1\u03b2, IL2, IL4, IL6, IL10, IL12p70, IL17A, IL17F, IFN\u03b3, TNF\u03b1) or a single-plex kit for TGF\u03b21 (both from EMD Millipore, Billerica, MA), according to the manufacturer\u2019s instructions and analyzed using a MagPix\u00ae reader with MilliPlex Analyst software (both from EMD Millipore).3",
            "startOffset": 30308,
            "title": "Assays of in vitro cytokine secretion"
        },
        {
            "endOffset": 40972,
            "parents": [],
            "secId": "s0120",
            "sentence": "As expected, treatment with the J-PG70 vaccine was either ineffective or slightly exacerbated disease in these models.",
            "startOffset": 40854,
            "title": "Discussion"
        },
        {
            "endOffset": 29133,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0045",
            "sentence": "Single cell suspensions from the spleens of mice with PGIA or GIA were processed as described.3",
            "startOffset": 29038,
            "title": "Spleen cell cultures"
        },
        {
            "endOffset": 37619,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 37618,
                    "startOffset": 37614
                }
            },
            "secId": "s0105",
            "sentence": "The relative inability of the DerG-PG70 vaccine to suppress IFN\u03b3 secretion by native or rhG1-stimulated spleen cells from GIA mice as opposed to a suppressive effect on IFN\u03b3 production by PGIA spleen cells might be due to the overproduction of IFN\u03b3 in the GIA model compared to the PGIA model, as demonstrated here and as reported previously [22].",
            "startOffset": 37272,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 33583,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0095",
            "sentence": "In Study 2, mice treated with DerG-PG70 in adjuvant had significantly (\u2217p < 0.05) reduced pannus formation and bone resorption as well as lower cumulative histopathology scores as compared to controls treated with PBS in adjuvant.",
            "startOffset": 33353,
            "title": "Histopathological changes"
        },
        {
            "endOffset": 28891,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0035",
            "sentence": "All animal procedures3 were approved by the Institutional Animal Care and Use Committee (IACUC) of Rush University Medical Center (IACUC permit number: 14-032).",
            "startOffset": 28731,
            "title": "Collection of blood and tissues from mice"
        },
        {
            "endOffset": 34755,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "The phenotypes of CD4+ T-cells within the spleen cell cultures of the treatment groups of PGIA and GIA mice were determined by flow cytometric evaluation of intracellular cytokines IFN\u03b3 (Th1), IL17 (Th17), or IL10, or the Treg cell marker, Foxp3, following in vitro stimulation with antigen (PG or rhG1).",
            "startOffset": 34451,
            "title": "T-cell phenotypes of splenocytes from vaccine treated PGIA and GIA mice"
        },
        {
            "endOffset": 36230,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "In the PGIA study, these ratios were significantly increased in favor of anti-inflammatory cytokine release in both the non-stimulated (Fig. 3A) and PG-stimulated (Fig. 3B) spleen cell cultures of DerG-PG70-treated mice as compared to PBS/adjuvant-treated controls.",
            "startOffset": 35965,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 39980,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "By comparing the binding of DerG-PG70 and J-PG70, two similar-sized peptides differing in the ICBL, the binding preference of the DerG-PG70 tetramer for CD4+ T-cells was evident.",
            "startOffset": 39802,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 42321,
            "parents": [],
            "secId": "s0120",
            "sentence": "In both models, the therapeutic effect of DerG-PG70 treatment was reflected in the reduction in IL17 production and the proportion of Th17 cells, critical players in RA pathogenesis.",
            "startOffset": 42139,
            "title": "Discussion"
        },
        {
            "endOffset": 27878,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0030",
            "sentence": "Briefly, mice with a similar average VA score in each group (ranging from 2 to 4 in the different studies) were sorted into treatment groups.",
            "startOffset": 27737,
            "title": "Vaccine treatment of mice with PGIA or GIA"
        },
        {
            "endOffset": 25848,
            "parents": [],
            "secId": "s0005",
            "sentence": "Binding of vaccine component peptides to different types of immune cells was examined to identify cells likely involved in the response to the vaccines.",
            "startOffset": 25696,
            "title": "Introduction"
        },
        {
            "endOffset": 36395,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "In the GIA study, the IL4:IL17(A + F) ratio was significantly increased in the in vitro non-stimulated (Fig. 3C), but not in the rhG1-stimulated cultures (Fig. 3C).",
            "startOffset": 36231,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 27376,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 27375,
                    "startOffset": 27368
                },
                "b0135": {
                    "endOffset": 27375,
                    "startOffset": 27368
                }
            },
            "secId": "s0025",
            "sentence": "Upon disease onset, the degree of arthritis for each paw was visually scored every other day on a scale of 0 to 4 for each limb, summing the individual paw scores to a maximum visual arthritis (VA) score of 16 per animal3 [25,27].",
            "startOffset": 27146,
            "title": "Mice, immunization, and visual assessment of arthritis"
        },
        {
            "endOffset": 31451,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0070",
            "sentence": "The avidity of peptide binding was increased by tetramerization of biotinylated (B)-peptides with streptavidin-phycoerythrin (SA-PE) according to a protein tetramerization protocol provided by the National Institutes of Health (NIH) Tetramer Core Facility (Emory University, Atlanta, GA).",
            "startOffset": 31163,
            "title": "Assay of peptide tetramer binding to cells"
        },
        {
            "endOffset": 28184,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0030",
            "sentence": "The vaccines (or control PBS in adjuvant) were administered s.c. at the nape of the neck into anesthetized mice.",
            "startOffset": 28072,
            "title": "Vaccine treatment of mice with PGIA or GIA"
        },
        {
            "endOffset": 39146,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 39145,
                    "startOffset": 39141
                }
            },
            "secId": "s0115",
            "sentence": "Tetramers were formed with SA-PE using a method developed for detecting the binding of MHC-peptide complexes to T-cells by flow cytometry [30].",
            "startOffset": 39003,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 40216,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "Tetramers containing the individual peptides (PG70, DerG or J) bound very weakly to all of the cell types examined (Fig. 5B).",
            "startOffset": 40091,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 25213,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 25142,
                    "startOffset": 25135
                },
                "b0110": {
                    "endOffset": 25155,
                    "startOffset": 25151
                },
                "b0130": {
                    "endOffset": 25142,
                    "startOffset": 25135
                }
            },
            "secId": "s0005",
            "sentence": "The PGIA [21,26] and GIA [22] models resemble human RA better than other animal models.",
            "startOffset": 25126,
            "title": "Introduction"
        },
        {
            "endOffset": 30307,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0055",
            "sentence": "For the PGIA study, the concentrations of cytokines were determined by ELISA (IFN\u03b3, IL17, IL4, IL10 kits (Peprotech, Rocky Hill, NJ) and transforming growth factor (TGF\u03b21; R & D Systems, Minneapolis, MN), according to the manufacturers\u2019 instructions.",
            "startOffset": 30057,
            "title": "Assays of in vitro cytokine secretion"
        },
        {
            "endOffset": 32486,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0090",
            "sentence": "In Study 3 (Fig. 1C), additional controls of peptides PG70 and DerG in adjuvant as well as PBS without adjuvant were tested.",
            "startOffset": 32362,
            "title": "Visual arthritis (VA) scores"
        },
        {
            "endOffset": 44136,
            "parents": [],
            "secId": "s0120",
            "sentence": "RA is different for different patients and failure to respond to certain therapies may reflect differences in the initiators and responses driving their disease.",
            "startOffset": 43975,
            "title": "Discussion"
        },
        {
            "endOffset": 45580,
            "parents": [],
            "secId": "s0130",
            "sentence": "Conceived and designed the experiments: D.H.Z., K.M., T.T.G. Performed the experiments: K.M., A.M., J.K., H.L.S., R.E.C., T.T.G. Analyzed the data: K.M., S.M.C., R.E.C., H.L.S., A.M., J.K., D.H.Z., T.T.G., K.S.R. Contributed reagents/materials/analysis tools: D.H.Z., T.T.G., K.M. Wrote the paper: D.H.Z., K.S.R., K.M., T.T.G.",
            "startOffset": 45254,
            "title": "Authors\u2019 contributions"
        },
        {
            "endOffset": 31661,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0075",
            "sentence": "The GraphPad Prism 6 software (GraphPad, La Jolla, CA) was used for both statistical analysis and plotting of data.",
            "startOffset": 31546,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 44703,
            "parents": [],
            "secId": "s0125",
            "sentence": "The following authors declare conflict of interest as specified:",
            "startOffset": 44639,
            "title": "Conflicts of interest"
        },
        {
            "endOffset": 28730,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0035",
            "sentence": "Spleens were harvested under aseptic conditions for in vitro studies, and hind limbs excised and fixed in formalin.",
            "startOffset": 28615,
            "title": "Collection of blood and tissues from mice"
        },
        {
            "endOffset": 37712,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "Ultimately, the pro-inflammatory response was reduced by DerG-PG70 treatment in both models.",
            "startOffset": 37620,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 39641,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 39622,
                    "startOffset": 39618
                }
            },
            "secId": "s0115",
            "sentence": "Specifically, the binding patterns to DCs were obscured by the high background fluorescence (e.g., SA-PE alone), possibly due to phagocytic activity of DCs [31] (Fig. 5A, bottom).",
            "startOffset": 39462,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 28538,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0035",
            "sentence": "Serum samples were stored at \u221270 \u00b0C until use.",
            "startOffset": 28492,
            "title": "Collection of blood and tissues from mice"
        },
        {
            "endOffset": 34170,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0095",
            "sentence": "While the effect of DerG-PG70 on reduction of inflammation, pannus formation, cartilage damage, bone resorption, periosteal bone formation, or summed scores did not always reach the level of statistical significance in Studies 2 and 3, a protective effect was indicated by strong reductions in these parameters in both studies (Table 1).",
            "startOffset": 33833,
            "title": "Histopathological changes"
        },
        {
            "endOffset": 41835,
            "parents": [],
            "secId": "s0120",
            "sentence": "The switch from a pro-inflammatory T-cell population to one favoring regulation and modulation by DerG-PG70 treatment in the spleen is likely to reflect the systemic changes seen in the curtailed progression of disease.",
            "startOffset": 41616,
            "title": "Discussion"
        },
        {
            "endOffset": 23048,
            "parents": [],
            "secId": "s0005",
            "sentence": "Vaccination as an immunotherapy is an alternative to treatment with either sDMARDs or bDMARDs and has the potential to modulate the different cells and cytokines involved in the ongoing autoimmune and inflammatory responses.",
            "startOffset": 22824,
            "title": "Introduction"
        },
        {
            "endOffset": 24938,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 24890,
                    "startOffset": 24886
                },
                "b0110": {
                    "endOffset": 24937,
                    "startOffset": 24933
                }
            },
            "secId": "s0005",
            "sentence": "Proteoglycan (PG)-induced arthritis (PGIA) and G1 domain (of PG) induced arthritis (GIA) are autoimmune animal models of RA,3 induced by intraperitoneal (i.p.) immunization of BALB/c female mice with PG of human articular cartilage [21] or the recombinant G1 domain (rhG1) of PG [22].",
            "startOffset": 24654,
            "title": "Introduction"
        },
        {
            "endOffset": 23532,
            "parents": [],
            "secId": "s0005",
            "sentence": "A key advantage of therapeutic vaccination is antigen specificity, which is focused on the disease initiators, but the vaccine must also modulate the aberrant ongoing immune reactions of the patient.",
            "startOffset": 23333,
            "title": "Introduction"
        },
        {
            "endOffset": 42011,
            "parents": [],
            "secId": "s0120",
            "sentence": "Although showing similar trends, the immune responses driving disease and subsequently, the responses to DerG-PG70 and J-PG70 for the PGIA and GIA models were subtly different.",
            "startOffset": 41835,
            "title": "Discussion"
        },
        {
            "endOffset": 44639,
            "parents": [],
            "secId": "s0125",
            "sentence": "Authors A.M., J.K., declare no conflict of interest.",
            "startOffset": 44587,
            "title": "Conflicts of interest"
        },
        {
            "endOffset": 41144,
            "parents": [],
            "secId": "s0120",
            "sentence": "Although the outcomes in the two disease systems were similar, there were differences in the kinetics of both disease development and vaccine effects between PGIA and GIA.",
            "startOffset": 40973,
            "title": "Discussion"
        },
        {
            "endOffset": 21903,
            "parents": [],
            "secId": "s0005",
            "sentence": "RA is a very heterogeneous disease that may have different initiators and be driven by different types of inflammatory responses for each individual.",
            "startOffset": 21754,
            "title": "Introduction"
        },
        {
            "endOffset": 22485,
            "parents": [],
            "secId": "s0005",
            "sentence": "Both sDMARDs and bDMARDS suppress elements of the entire immune system in order to curtail the inflammatory process.",
            "startOffset": 22369,
            "title": "Introduction"
        },
        {
            "endOffset": 27145,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0025",
            "sentence": "Mice were inspected for signs of arthritis (swelling and redness) twice a week after the second PG immunization.",
            "startOffset": 27033,
            "title": "Mice, immunization, and visual assessment of arthritis"
        },
        {
            "endOffset": 39461,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "Although the DerG-PG70 tetramer bound to CD4+ T-cells (Fig. 5A, top) better than the other ligands, binding specificity to the other cell types was relatively difficult to discern.",
            "startOffset": 39281,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 42604,
            "parents": [],
            "secId": "s0120",
            "sentence": "The ICBL component of a LEAPS vaccine attached to the disease related antigenic peptide promotes interaction with immune cells and hence directs the subsequent immune response.",
            "startOffset": 42428,
            "title": "Discussion"
        },
        {
            "endOffset": 30840,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0060",
            "sentence": "Cytokine levels in the serum samples of GIA mice were measured using the MagPix\u00ae technology as described above for cell culture supernatants.",
            "startOffset": 30699,
            "title": "Serum cytokine assays"
        },
        {
            "endOffset": 32939,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0090",
            "sentence": "Importantly, the DerG-PG70 vaccine effectively curtailed arthritis symptoms in GIA (Fig. 1B and 1C) despite its more aggressive disease course compared to PGIA (Fig. 1A).",
            "startOffset": 32769,
            "title": "Visual arthritis (VA) scores"
        },
        {
            "endOffset": 29359,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0045",
            "sentence": "The spleen cells were seeded into 48-well culture plates (3 \u00d7 106 viable cells per well) in the absence or presence of PG (50 \u00b5g/ml) or rhG1 (7.5 \u00b5g/ml) for cells from PGIA and GIA mice, respectively, and cultured for 4 days.",
            "startOffset": 29134,
            "title": "Spleen cell cultures"
        },
        {
            "endOffset": 43975,
            "parents": [],
            "secId": "s0120",
            "sentence": "Focusing the therapy on the inflammatory disease-promoting immune responses in an antigen-specific manner with LEAPS vaccines appears to bring the system to an appropriate balance, presumably without loss of important immune protections.",
            "startOffset": 43738,
            "title": "Discussion"
        },
        {
            "endOffset": 31522,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0070",
            "sentence": "Peptide binding to cells was detected by flow cytometry as described.3",
            "startOffset": 31452,
            "title": "Assay of peptide tetramer binding to cells"
        },
        {
            "endOffset": 43495,
            "parents": [],
            "secId": "s0120",
            "sentence": "The ability of DerG-PG70 to steer T-cells away from pro-inflammatory responses and promote anti-inflammatory/regulatory activities explains the therapeutic success of DerG-PG70 in restricting the progression of disease in the treated PGIA and GIA mice.",
            "startOffset": 43243,
            "title": "Discussion"
        },
        {
            "endOffset": 27610,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0025",
            "sentence": "The limbs of animals with GIA were visually scored for the degree of arthritis 3 times a week as described for PGIA.3",
            "startOffset": 27493,
            "title": "Mice, immunization, and visual assessment of arthritis"
        },
        {
            "endOffset": 39280,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "However, as the LEAPS heteroconjugate peptides contained a cell binding ligand (either DerG or J), addition of MHC was not necessary.",
            "startOffset": 39147,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 25695,
            "parents": [],
            "secId": "s0005",
            "sentence": "T-cell phenotypes and production of cytokines were also examined in vitro using spleen cells from vaccinated and control diseased animals.",
            "startOffset": 25557,
            "title": "Introduction"
        },
        {
            "endOffset": 40853,
            "parents": [],
            "secId": "s0120",
            "sentence": "Indeed, the DerG-PG70 vaccine reproducibly curtailed the progression of disease in PGIA and two independent GIA studies as indicated by the VA scores of in vivo monitored animals and joint histopathology.",
            "startOffset": 40649,
            "title": "Discussion"
        },
        {
            "endOffset": 43098,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 42981,
                    "startOffset": 42965
                },
                "b0055": {
                    "endOffset": 43097,
                    "startOffset": 43087
                },
                "b0060": {
                    "endOffset": 43097,
                    "startOffset": 43087
                },
                "b0065": {
                    "endOffset": 42981,
                    "startOffset": 42965
                },
                "b0070": {
                    "endOffset": 42981,
                    "startOffset": 42965
                },
                "b0075": {
                    "endOffset": 42981,
                    "startOffset": 42965
                },
                "b0080": {
                    "endOffset": 42981,
                    "startOffset": 42965
                },
                "b0100": {
                    "endOffset": 43097,
                    "startOffset": 43087
                },
                "b0165": {
                    "endOffset": 42981,
                    "startOffset": 42965
                },
                "b0170": {
                    "endOffset": 42981,
                    "startOffset": 42965
                }
            },
            "secId": "s0120",
            "sentence": "Preference for CD4+ T-cells is in keeping with previous studies for the DerG ICBL peptide [10,13\u201316,33,34], and preference for APCs for the J ICBL, is consistent with its ability to promote the maturation of DCs [11,12,20].",
            "startOffset": 42875,
            "title": "Discussion"
        },
        {
            "endOffset": 35041,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0100",
            "sentence": "Treatment of PGIA (Fig. 2A) or GIA (Fig. 2B) mice with the DerG-PG70 vaccine led to a reduction of pro-inflammatory Th1 and Th17 cells (even after antigen stimulation) and an increase in the frequency of anti-inflammatory IL10-producing as well as protective Treg cells in both models.",
            "startOffset": 34756,
            "title": "T-cell phenotypes of splenocytes from vaccine treated PGIA and GIA mice"
        },
        {
            "endOffset": 28383,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0030",
            "sentence": "Monitoring of the VA scores continued three weeks after the second vaccination.3",
            "startOffset": 28303,
            "title": "Vaccine treatment of mice with PGIA or GIA"
        },
        {
            "endOffset": 41615,
            "parents": [],
            "secId": "s0120",
            "sentence": "DerG-PG70 treatment promoted more balanced, less inflammatory cytokine responses by increasing Th2 (IL4+ and IL10+) and Treg (Foxp3+ and TGF\u03b21+) cells and reducing Th1 and Th17 cells in PGIA, and to a somewhat lesser extent in the GIA system, as represented by the T-cell phenotypes from the treated animals.",
            "startOffset": 41307,
            "title": "Discussion"
        },
        {
            "endOffset": 44850,
            "parents": [],
            "secId": "s0125",
            "sentence": "K.S.R. is inventor on some LEAPS-related patents or patent applications.",
            "startOffset": 44778,
            "title": "Conflicts of interest"
        },
        {
            "endOffset": 27032,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 26899,
                    "startOffset": 26892
                },
                "b0125": {
                    "endOffset": 27031,
                    "startOffset": 27027
                },
                "b0130": {
                    "endOffset": 26899,
                    "startOffset": 26892
                }
            },
            "secId": "s0025",
            "sentence": "To induce PGIA, mice were immunized i.p. with human PG (100 \u03bcg protein in 100 \u00b5l sterile phosphate-buffered saline (PBS, pH 7.2)) [21,26] emulsified in dimethyl-dioctadecyl ammonium bromide adjuvant (DDA; Sigma-Aldrich, St Louis, MO) three times, three weeks apart [25].",
            "startOffset": 26762,
            "title": "Mice, immunization, and visual assessment of arthritis"
        },
        {
            "endOffset": 44405,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 44404,
                    "startOffset": 44400
                }
            },
            "secId": "s0120",
            "sentence": "In this study, the DerG-PG70 vaccine was effective in curtailing progression of arthritis driven by Th1 responses whereas a collagen peptide-containing J-LEAPS vaccine, CEL-2000, was effective in blocking the progression of arthritis in the Th17-driven CIA model [17].",
            "startOffset": 44137,
            "title": "Discussion"
        },
        {
            "endOffset": 23770,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0200": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0205": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0210": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0215": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0220": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0225": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0230": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0235": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0240": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "b0245": {
                    "endOffset": 23591,
                    "startOffset": 23566
                },
                "s0145": {
                    "endOffset": 23591,
                    "startOffset": 23566
                }
            },
            "secId": "s0005",
            "sentence": "LEAPS3 (Ligand Epitope Antigen Presentation System) vaccines offer the opportunity to immunize with a disease-related antigen and concurrently modulate the subsequent immune response.",
            "startOffset": 23532,
            "title": "Introduction"
        },
        {
            "endOffset": 26517,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0020",
            "sentence": "Human cartilage PG and rhG1 protein were prepared as described.3",
            "startOffset": 26453,
            "title": "Antigens used for inducing arthritis"
        },
        {
            "endOffset": 35964,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "We specifically focused on the ratios of anti-inflammatory (IL4 or IL10) to pro-inflammatory (IFN\u03b3 or IL17) T-cell cytokines in the spleen cell cultures of PGIA and GIA mice (Fig. 3) as calculated from the concentrations of secreted cytokines (Supplementary Fig. 3).3",
            "startOffset": 35697,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 26762,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0025",
            "sentence": "Adult (retired breeder) female BALB/c mice were obtained from the National Cancer Institute (NCI; Frederick, MD) or from the former NCI facility acquired by Charles River (Wilmington, MA).",
            "startOffset": 26574,
            "title": "Mice, immunization, and visual assessment of arthritis"
        },
        {
            "endOffset": 35276,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "Cytokine production from cell cultures prepared from the spleens of vaccinated mice were measured to evaluate ongoing or antigen-induced responses.",
            "startOffset": 35129,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 38532,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "Ratios of anti-inflammatory T-cell cytokines (IL4 and IL10) to pro-inflammatory T-cell cytokines (IL17(A + F) and IFN\u03b3) in serum from DerG-PG70 treated mice were significantly increased in favor of anti-inflammatory responses (Fig. 4A and B).",
            "startOffset": 38290,
            "title": "Serum levels of cytokines"
        },
        {
            "endOffset": 24401,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 24400,
                    "startOffset": 24396
                }
            },
            "secId": "s0005",
            "sentence": "The LEAPS vaccine CEL-2000 (a conjugate composed of a J ICBL and an immunodominant type II collagen (CII) epitope) was shown to be therapeutic when administered after the onset of disease symptoms in collagen induced arthritis (CIA), a Th17-driven mouse model of RA [17].",
            "startOffset": 24130,
            "title": "Introduction"
        },
        {
            "endOffset": 45017,
            "parents": [],
            "secId": "s0125",
            "sentence": "R.E.C., S.M.C. and H.L.S. are inventors on patent applications related to this study, and they are employees and stockholders or option holders of CEL-SCI Corporation.",
            "startOffset": 44850,
            "title": "Conflicts of interest"
        },
        {
            "endOffset": 22368,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 22367,
                    "startOffset": 22364
                }
            },
            "secId": "s0005",
            "sentence": "The two primary treatment modalities are synthetic, small molecule disease-modifying anti-rheumatic drugs (sDMARDs), and biologic large molecule DMARDs (bDMARDs) [8].",
            "startOffset": 22202,
            "title": "Introduction"
        },
        {
            "endOffset": 43737,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 43528,
                    "startOffset": 43521
                },
                "b0175": {
                    "endOffset": 43528,
                    "startOffset": 43521
                }
            },
            "secId": "s0120",
            "sentence": "Unlike cytokine ablation [23,35], which also suppresses PGIA, DerG-PG70 appears to act directly on the T-cell drivers of the immune response rather than the subsequently elicited arthritis related cytokines to ameliorate disease progression.",
            "startOffset": 43496,
            "title": "Discussion"
        },
        {
            "endOffset": 25401,
            "parents": [],
            "secId": "s0005",
            "sentence": "We report here the results of testing J-LEAPS (J-PG70) and DerG-LEAPS (DerG-PG70, also called CEL-4000) vaccines, heteroconjugates with the PG70 peptide,3 in the PGIA and GIA models of RA.",
            "startOffset": 25213,
            "title": "Introduction"
        },
        {
            "endOffset": 27736,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0030",
            "sentence": "Vaccine treatment was initiated after the mice developed arthritis (PGIA or GIA).",
            "startOffset": 27655,
            "title": "Vaccine treatment of mice with PGIA or GIA"
        },
        {
            "endOffset": 31117,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 31115,
                    "startOffset": 31111
                }
            },
            "secId": "s0065",
            "sentence": "DCs (MHC class II+ CD11c+ cells) constituted over 60% of the collected cell population, as determined by flow cytometry [29].3",
            "startOffset": 30991,
            "title": "Generation of bone marrow-derived dendritic cells (BM-DCs)"
        },
        {
            "endOffset": 33832,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0095",
            "sentence": "In Study 3, DerG-PG70-treated animals demonstrated significantly reduced degree of inflammation, cartilage damage, and cumulative histopathology score, while J-PG70-treated mice generally had greater joint damage than PBS/adjuvant-treated controls.",
            "startOffset": 33584,
            "title": "Histopathological changes"
        },
        {
            "endOffset": 39002,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "SA-PE-B-Peptide tetramers were prepared to increase the avidity and add fluorescence to the peptide ligands to facilitate analysis of their binding to cells.",
            "startOffset": 38845,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 40090,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0115",
            "sentence": "Similarly, the binding preference of J-PG70 for MHC II-bearing cells (APCs) and CD11c+ BM-DCs became evident.",
            "startOffset": 39981,
            "title": "Binding of LEAPS conjugates and related individual peptides to immune cells in vitro"
        },
        {
            "endOffset": 28491,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0035",
            "sentence": "At the end of the experiments, mice were anesthetized, and bled.",
            "startOffset": 28427,
            "title": "Collection of blood and tissues from mice"
        },
        {
            "endOffset": 32768,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                },
                {
                    "id": "s0085",
                    "title": "DerG-PG70 LEAPS vaccine limits arthritis progression in vivo"
                }
            ],
            "secId": "s0090",
            "sentence": "As indicated by the VA scores, treatment with the DerG-PG70 vaccine significantly (\u2217p < 0.05) limited disease progression within 3 weeks in all three studies whereas J-PG70 or individual peptides had no significant effects as compared with the PBS/adjuvant or PBS control (Fig. 1).",
            "startOffset": 32487,
            "title": "Visual arthritis (VA) scores"
        },
        {
            "endOffset": 27492,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 27491,
                    "startOffset": 27487
                }
            },
            "secId": "s0025",
            "sentence": "Similarly, groups of mice were immunized with rhG1 (40 \u00b5g per injection in DDA) i.p. three times to induce GIA [22].",
            "startOffset": 27376,
            "title": "Mice, immunization, and visual assessment of arthritis"
        },
        {
            "endOffset": 37271,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 37270,
                    "startOffset": 37266
                }
            },
            "secId": "s0105",
            "sentence": "Differences in the results between the PGIA and GIA spleen cell cytokine secretion studies may reflect differences in the detection methods (i.e., ELISA versus MagPix\u00ae with the latter being more sensitive than the former), but it is more likely that they reflect differences between the two animal models [22].",
            "startOffset": 36961,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 26150,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0015",
            "sentence": "The sequences of the peptides used for the in vivo and in vitro studies were as follows: PG70 (ATEGRVRVNSAYQDK), DerG (DGQEEKAGVVSTGLIGGG), J (DLLKNGERIEKVEGGG), and conjugates DerG-PG70 (DGQEEKAGVVSTGLIGGGATEGRVRVNSAYQDK) and J-PG70 (DLLKNGERIEKVEGGGATEGRVRVNSAYQDK).",
            "startOffset": 25882,
            "title": "Peptides"
        },
        {
            "endOffset": 30056,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0055",
            "sentence": "On the fourth day of culture, the plates were centrifuged, supernatants were collected and frozen at \u221270 \u00b0C.",
            "startOffset": 29948,
            "title": "Assays of in vitro cytokine secretion"
        },
        {
            "endOffset": 42428,
            "parents": [],
            "secId": "s0120",
            "sentence": "The reduction in these pro-inflammatory responses was likely due to increases in Th2 and/or Treg activity.",
            "startOffset": 42322,
            "title": "Discussion"
        },
        {
            "endOffset": 35696,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "Cytokine production by spleen cells receiving no additional in vitro antigen stimulation represent cellular responses resulting from the combination of the effects of disease and vaccine treatments on the mice, whereas cytokine production following in vitro antigen stimulation represents additional antigen-specific responses resulting from the combined effects of disease, vaccination, and in vitro antigen treatment.",
            "startOffset": 35277,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 38037,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "Concentrations of 10 different cytokines (IL4, TNF\u03b1, IFN\u03b3, IL2, IL1\u03b2, IL6, IL10, IL12p70, IL17A, and IL17F) in serum samples from LEAPS-vaccinated and control GIA mice (Studies 2 and 3) were evaluated as an additional indication of the action of DerG-PG70 on the immune and inflammatory processes.",
            "startOffset": 37740,
            "title": "Serum levels of cytokines"
        },
        {
            "endOffset": 45231,
            "parents": [],
            "secId": "s0125",
            "sentence": "D.H.Z. is a discoverer of LEAPS technology, inventor on LEAPS patents and patent applications related to this study, and he is also a Company officer, employee, stockholder and option holder of CEL-SCI Corporation.",
            "startOffset": 45017,
            "title": "Conflicts of interest"
        },
        {
            "endOffset": 23909,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 23908,
                    "startOffset": 23904
                }
            },
            "secId": "s0005",
            "sentence": "LEAPS vaccines are heteroconjugate peptides composed of a disease-specific antigenic epitope and an immune cell binding ligand (ICBL)[10].",
            "startOffset": 23771,
            "title": "Introduction"
        },
        {
            "endOffset": 21753,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 21752,
                    "startOffset": 21747
                },
                "b0010": {
                    "endOffset": 21752,
                    "startOffset": 21747
                },
                "b0015": {
                    "endOffset": 21752,
                    "startOffset": 21747
                },
                "b0020": {
                    "endOffset": 21752,
                    "startOffset": 21747
                },
                "b0025": {
                    "endOffset": 21752,
                    "startOffset": 21747
                },
                "b0030": {
                    "endOffset": 21752,
                    "startOffset": 21747
                }
            },
            "secId": "s0005",
            "sentence": "Rheumatoid arthritis (RA) is an autoimmune disorder characterized by chronic inflammation and systemic destruction of the peripheral joints [1\u20136].",
            "startOffset": 21607,
            "title": "Introduction"
        },
        {
            "endOffset": 36961,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0105",
            "sentence": "In the cell cultures from GIA mice, DerG-PG70 vaccination resulted in significant reductions in the production of IL17(A + F) and IFN\u03b3, but other cytokines were affected to a lesser degree (Supplementary Fig. 3C and 3D).3",
            "startOffset": 36740,
            "title": "In vitro secretion of cytokines by splenocytes from vaccine-treated PGIA and GIA mice"
        },
        {
            "endOffset": 22824,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 22823,
                    "startOffset": 22818
                },
                "b0045": {
                    "endOffset": 22823,
                    "startOffset": 22818
                }
            },
            "secId": "s0005",
            "sentence": "IL17-targeting therapies still only treat the symptoms, do not act on the source of the inflammatory pathways, are not disease- or antigen-specific, and may ablate important anti-microbial immune responses [6,9].",
            "startOffset": 22612,
            "title": "Introduction"
        },
        {
            "endOffset": 31818,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "secId": "s0075",
            "sentence": "The statistical tests used as well as other details are provided in the Figure Captions and in the footnote to Table 1.",
            "startOffset": 31699,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 38289,
            "parents": [
                {
                    "id": "s0080",
                    "title": "Results"
                }
            ],
            "secId": "s0110",
            "sentence": "In both GIA studies, IL17F serum levels were significantly reduced in DerG-PG70-treated mice as compared to the PBS/adjuvant-treated controls, but the concentrations of other cytokines were comparable among the treatment groups (Supplementary Fig. 4).",
            "startOffset": 38038,
            "title": "Serum levels of cytokines"
        },
        {
            "endOffset": 29015,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods3"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 29014,
                    "startOffset": 29004
                },
                "b0125": {
                    "endOffset": 29014,
                    "startOffset": 29004
                },
                "b0130": {
                    "endOffset": 29014,
                    "startOffset": 29004
                },
                "b0135": {
                    "endOffset": 29014,
                    "startOffset": 29004
                }
            },
            "secId": "s0040",
            "sentence": "Hind limbs tissue sections were prepared, processed, examined, photographed and scored as described3 [21,25\u201327].",
            "startOffset": 28903,
            "title": "Histology"
        },
        {
            "endOffset": 44778,
            "parents": [],
            "secId": "s0125",
            "sentence": "K.M. and T.T.G. are inventors on patent applications related to this study.",
            "startOffset": 44703,
            "title": "Conflicts of interest"
        },
        {
            "endOffset": 25556,
            "parents": [],
            "secId": "s0005",
            "sentence": "The effects of vaccines on the disease process, joint histopathology, and serum levels of anti-inflammatory and pro-inflammatory cytokines were evaluated.",
            "startOffset": 25402,
            "title": "Introduction"
        },
        {
            "endOffset": 24495,
            "parents": [],
            "secId": "s0005",
            "sentence": "The therapeutic effect was accompanied by reduced serum levels of pro-inflammatory cytokines.",
            "startOffset": 24402,
            "title": "Introduction"
        },
        {
            "endOffset": 24654,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 24653,
                    "startOffset": 24640
                },
                "b0060": {
                    "endOffset": 24653,
                    "startOffset": 24640
                },
                "b0090": {
                    "endOffset": 24602,
                    "startOffset": 24598
                },
                "b0095": {
                    "endOffset": 24653,
                    "startOffset": 24640
                },
                "b0100": {
                    "endOffset": 24653,
                    "startOffset": 24640
                }
            },
            "secId": "s0005",
            "sentence": "Other J-LEAPS heteroconjugate vaccines were effective in treating experimental autoimmune myocarditis [18] or viral infections in animal models [11,12,19,20].",
            "startOffset": 24496,
            "title": "Introduction"
        }
    ],
    "docId": "S0264410X17306072",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "Katalin_Mikecz@rush.edu",
                "first": "Katalin",
                "initial": "K.",
                "last": "Mikecz"
            },
            {
                "email": "Tibor_Glant@rush.edu",
                "first": "Tibor T.",
                "initial": "T.T.",
                "last": "Glant"
            },
            {
                "email": "Adrienn_Markovics@rush.edu",
                "first": "Adrienn",
                "initial": "A.",
                "last": "Markovics"
            },
            {
                "email": "krosenthal@roseman.edu",
                "first": "Kenneth S.",
                "initial": "K.S.",
                "last": "Rosenthal"
            },
            {
                "email": "kurkojulcsi@gmail.com",
                "first": "Julia",
                "initial": "J.",
                "last": "Kurko"
            },
            {
                "email": "rcarambula@cel-sci.com",
                "first": "Roy E.",
                "initial": "R.E.",
                "last": "Carambula"
            },
            {
                "email": "scress@cel-sci.com",
                "first": "Steve",
                "initial": "S.",
                "last": "Cress"
            },
            {
                "email": "hstein3@gmail.com",
                "first": "Harold L.",
                "initial": "H.L.",
                "last": "Steiner"
            },
            {
                "email": "dzimmerman@cel-sci.com",
                "first": "Daniel H.",
                "initial": "D.H.",
                "last": "Zimmerman"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.05.009",
        "firstpage": "4048",
        "issn": "0264410X",
        "keywords": [
            "Autoimmunity",
            "Cytokines",
            "Immunotherapy",
            "Murine models",
            "Peptide vaccine",
            "Rheumatoid arthritis",
            "Therapeutic vaccine"
        ],
        "lastpage": "4056",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis"
    }
}